KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis
USA - NASDAQ:KEQU - US4928541048 - Common Stock
41.28 USD
+0.07 (+0.17%)
We assign a fundamental rating of 5 out of 10 to KEQU. KEQU was compared to 189 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year KEQU was profitable.
In the past year KEQU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
1.2 Ratios
KEQU has a better Return On Assets (6.36%) than 86.24% of its industry peers.
With an excellent Return On Equity value of 18.34%, KEQU belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
KEQU's Return On Invested Capital of 10.92% is amongst the best of the industry. KEQU outperforms 91.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 9.12%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
KEQU's Profit Margin of 4.68% is fine compared to the rest of the industry. KEQU outperforms 75.66% of its industry peers.
KEQU has a Operating Margin of 7.60%. This is in the better half of the industry: KEQU outperforms 75.13% of its industry peers.
KEQU has a Gross Margin of 29.37%. This is in the lower half of the industry: KEQU underperforms 75.66% of its industry peers.
KEQU's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
KEQU has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for KEQU has been increased compared to 5 years ago.
Compared to 1 year ago, KEQU has a worse debt to assets ratio.
2.2 Solvency
KEQU has an Altman-Z score of 3.12. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.12, KEQU is in the better half of the industry, outperforming 70.90% of the companies in the same industry.
KEQU has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as KEQU would need 3.45 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.45, KEQU belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
A Debt/Equity ratio of 0.91 indicates that KEQU is somewhat dependend on debt financing.
The Debt to Equity ratio of KEQU (0.91) is worse than 75.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.12 |
ROIC/WACC1.4
WACC7.78%
2.3 Liquidity
A Current Ratio of 2.32 indicates that KEQU has no problem at all paying its short term obligations.
KEQU's Current ratio of 2.32 is in line compared to the rest of the industry. KEQU outperforms 45.50% of its industry peers.
A Quick Ratio of 1.63 indicates that KEQU should not have too much problems paying its short term obligations.
The Quick ratio of KEQU (1.63) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.65%.
Looking at the last year, KEQU shows a very strong growth in Revenue. The Revenue has grown by 30.09%.
KEQU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.27% yearly.
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.97 indicates a reasonable valuation of KEQU.
Based on the Price/Earnings ratio, KEQU is valued cheaper than 92.59% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.13, KEQU is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.97 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KEQU is valued cheaper than 98.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.33 | ||
| EV/EBITDA | 6.39 |
4.3 Compensation for Growth
The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
KEQU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:KEQU (11/5/2025, 8:05:35 PM)
41.28
+0.07 (+0.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner Change0.07%
Ins Owners16.53%
Ins Owner Change1.44%
Market Cap118.47M
Revenue(TTM)263.18M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %2.2%
Short Ratio3.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.97 | ||
| Fwd PE | N/A | ||
| P/S | 0.45 | ||
| P/FCF | 6.33 | ||
| P/OCF | 5.54 | ||
| P/B | 1.77 | ||
| P/tB | 3.19 | ||
| EV/EBITDA | 6.39 |
EPS(TTM)4.14
EY10.03%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY15.79%
OCF(TTM)7.45
OCFY18.04%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.12 |
F-Score4
WACC7.78%
ROIC/WACC1.4
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
ChartMill assigns a fundamental rating of 5 / 10 to KEQU.
Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?
ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.
How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.
Can you provide the dividend sustainability for KEQU stock?
The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.